Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Globus Medical, Inc. or iRhythm Technologies, Inc. is a better investment based on AAII's A+ ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...

Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $294.81 today based on a price of $75.50 for GMED at the time of writing.

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...